Literature DB >> 28748891

Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients: A Hospital-based cross-sectional study.

Praveen Kumar Etta1, R K Sharma1, Amit Gupta1.   

Abstract

We aim to evaluate the disturbances in mineral metabolism, abnormalities in bone mineral density (BMD), and extraskeletal calcification in newly detected, untreated predialysis stage 4 and 5 chronic kidney disease (CKD) patients at a tertiary care hospital in North India. This is cross-sectional observational study. A total of 95 (68 males, 27 females) newly detected patients underwent clinical evaluation, biochemical assessment [serum calcium, phosphorus, alkaline phosphatase (ALP), albumin, creatinine, intact parathyroid hormone (iPTH), 25- hydroxyvitamin D (25(OH)D)], BMD measurement (at spine, hip, and forearm) by dual-energy X-ray absorptiometry (DXA), lateral abdominal radiograph [for abdominal aortic calcification (AAC)], skeletal survey (to look for any abnormality including fractures), and echocardiography [for any cardiac valvular calcification (CVC)]. Symptoms related to CKD-mineral bone disorder were seen in 33.6% of the study patients. Prevalence of hypocalcemia, hyperphosphatemia, hyperparathyroidism, and hypovitaminosis D was 64.2%, 81.1%, 49.5%, and 89.5%, respectively. CVC was seen in 22.1% of patients on echocardiography, mostly involving the mitral valve. Patients with CVC were more likely to be males and smokers. There was no significant difference in iPTH levels between patients with or without CVC. AAC was seen in 10.5% of patients on lateral abdominal X-ray. Patients with AAC had higher levels of iPTH, phosphorus, and ALP and lower levels of calcium compared to patients without AAC. BMD by DXA showed a low bone mass in 41.05% of our patients and was more prevalent in CKD stage 5. Most of the study patients had hyperparathyroidism and low 25(OH)D levels. Our study shows that newly detected, naïve Indian CKD patients have a high prevalence of disturbances of mineral metabolism including hyperparathyroidism, Vitamin D deficiency, abnormal BMD, and valvular and vascular calcification, even before initiating dialysis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28748891

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  5 in total

1.  Identifying risk groups of infectious spondylitis in patients with end-stage renal disease under hemodialysis: a propensity score-matched case-control study.

Authors:  Kun-Lin Lu; Wen-Hung Huang; Yueh-An Lu; Chan-Yu Lin; Hsin-Hsu Wu; Ching-Wei Hsu; Cheng-Hao Weng; Chao-Yi Wu; I-Wen Wu; Meng-Yu Wu; Tzung-Hai Yen; Huang-Yu Yang
Journal:  BMC Nephrol       Date:  2019-08-16       Impact factor: 2.388

2.  KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention and Prevention of Chronic Kidney Disease-Mineral and Bone Disorder (CKDMBD): Indian Commentary.

Authors:  Anna T Valson; Manisha Sahay; Narayan Prasad; Sanjay Kumar Agarwal; Santosh Varughese; Sishir Gang
Journal:  Indian J Nephrol       Date:  2020-07-30

Review 3.  Understanding the Stony Bridge between Osteoporosis and Vascular Calcification: Impact of the FGF23/Klotho axis.

Authors:  Xu Wei; Xinyi Huang; Ning Liu; Baoyu Qi; Shengjie Fang; Yili Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-08-30       Impact factor: 6.543

4.  Analysis of the Prevalence and Severity of Dysregulated Bone Mineral Homeostasis in Nondialyzed Chronic Kidney Disease Patients.

Authors:  Digishaben D Patel; Uday Vachhani; Ajay Rajput; Pratik Raghavani; Deepak N Parchwani; Sagar Dholariya
Journal:  J Lab Physicians       Date:  2021-07-14

Review 5.  Calcification of Cardiac Valves in Metabolic Bone Disease: An Updated Review of Clinical Studies.

Authors:  Paolo Carrai; Silvia Camarri; Carlo Renato Pondrelli; Stefano Gonnelli; Carla Caffarelli
Journal:  Clin Interv Aging       Date:  2020-07-09       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.